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ABSRACT
The prevalence of antibiotic resistant bacteria has made the choices for topical treatments for
patients who experience burns wounds extremely limited. The Staphylococcus genus is naturally
occurring in and on the human body but can become harmful once it enters the bloodstream. A
novel antimicrobial gel has been shown by our laboratory to inhibit both the planktonic growth
and biofilm formation of Staphylococcus aureus in previous studies. The antimicrobial gel is
made of seven natural compounds including antioxidants (vitamin C and E). We wanted to
examine the effects of the antimicrobial gel on numerous other Staphylococcal species because it
is prevalent on the body and becomes harmful when the immune system is compromised. The
species tested were Staphylococcus capitis, Staphylococcus epidermidis, and Staphylococcus
saprophyticus. A planktonic broth challenge test, biofilm attachment test, and biofilm maturation
test were all performed in order to test this hypothesis. These tests showed a significant
inhibition of the Staphylococcus species as a result of the effects of the antimicrobial gel. The
antimicrobial gel inhibited the attachment, maturation, and growth of Staphylococcus colonies in
a 10% antimicrobial gel solution. The antimicrobial gel shows promise as an option in treating
burn patients and should be considered in further testing for its uses in other areas of medicine.
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INTRODUCTION
Staphylococcus species
Staphylococcus is a Gram-positive genus of bacteria, which can become pathogenic to
humans and other animals (1). Staphylococcus typically grows in clusters, pairs, or short chains
when the Staphylococci divide into two planes (1). This genus is commonly divided into
coagulase-positive Staphylococci and coagulase-negative Staphylococci, although this does not
distinguish its virulence factor, but can be used as a marker for Staphylococcus aureus (S.
aureus) in most cases (1). Staphylococcus has multifactorial pathogenesis, making it difficult to
determine the role of each factor (1). Although, strains from isolated diseases have shown
expression in particular factors (1). The Staphylococcus species is the cause of many infections
associated with internal medical devices. Staphylococcus adheres to fibrinogen and fibronectin
host cells, which become prevalent on internal medical devices after implantation (1). S. aureus
can also bind to endothelial tissue, but the mechanism of adherence remains unclear. α-toxin, βtoxin, δ-toxin, γ-toxin and leucocidin are all membrane damaging toxins (1). Treatments for
Staphylococcal infections include the surgical removal of the medical device and antibiotics if
the strain is not resistant (1). Numerous strains of Staphylococcus were shown to develop
resistance to methicillin and penicillin in the mid 20th century, making vancomycin the primary
form of treatment for methicillin resistant S. aureus until Vancomycin resistant strains appeared
in the 1980’s (2). These antibiotic resistant strains have continued to become more prevalent in
hospitals and there appears to be no new antibiotics to combat the quickly adapting species.
Staphylococcus epidermidis
Staphylococcus epidermidis (S. epidermis), while previously viewed as an innocuous
microorganism residing on the skin, now presents as an opportunistic pathogen due to the rise in
nosocomial infections it causes making it comparable to S. aureus (3, 4). Along with nosocomial
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infections S. epidermidis is recognized as the most common source of infection on internal
medical devices due to the nature of insertion of these devices during surgery (4,5). The devices
come into contact with the skin and carry S. epidermidis with them once implanted. S.
epidermidis does not appear to be life threatening, but is important due to the frequency and
difficulty treating as a result of antibiotic resistance and biofilm formation (4).
S. epidermidis is the most commonly isolated microorganism from the human skin and
has the ability to acclimate to extreme salt concentrations as well as to varying osmotic pressures
of the environment (4). It is a very diverse coagulase-negative Staphylococcus species with 74
identified, unique deoxyribose nucleic acid (DNA) sequences (6,4). It causes the highest number
of infections among coagulase-negative Staphylococci (CoNS) bacteria and accounts for 22% of
bloodstream infections in intensive care unit patients in the USA (3,4). It has been shown that S.
epidermidis was involved in prosthetic joint, vascular graft, surgical site, central nervous system
shunt, and cardiac device infections as well as accounting for 13% of prosthetic valve
endocarditis infections, according to Chu, cited by Otto. (4,7)
Staphylococcus capitis
Staphylococcus capitis (S. capitis), just like S. epidermidis, is an opportunistic human
pathogen and a coagulase-negative Staphylococci bacterium (8). The findings by Van Der Zwet
and Rasigade cited by Cameron indicate that S. capitis causes up to 20% of neonatal sepsis cases
in the neonatal ICU (9, 10, 11). It has also contributed to the development of prosthetic valve
endocarditis and hospital-acquired meningitis in patients (12,9). It is interesting to note that
CoNS bacteria rely on biofilm formation for their virulence (9, 13). Biofilm production has been
associated with virulence in the absence of prosthetic material in an animal model (13). This
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study also found that gene regulation was involved in bacterial virulence, rather than the ica
operon, as previously suspected (13).
Staphylococcus saprophyticus
Staphylococcus saprophyticus (S. Saprophyticus) is a CoNS bacterium that is a common
cause of uncomplicated urinary tract infections, making up 42% of all infections, especially
effecting women ages 16-25 who are sexually active (14). Although more uncommon it is also
responsible for acute pyelonephritis, urethritis, epididymitis, and prostatitis (14). Unlike other
CoNS bacteria, it is known to be resistant to the antibiotic, Novobiocin, an aminocoumarin. (14).
Another study showed that a third of S. saprophyticus urinary tract infection cases were resistant
to oxacillin, a beta lactam antibiotic. (15) Some strains have the ability to create biofilms to
increase their virulence and resistance (14). This bacterium colonizes in the perineum, rectum,
urethra, cervix, and gastrointestinal tract (14). There is an increased incidence of S.
saprophyticus infection in patients with nosocomial urinary tract infections, pregnant patients,
and patients who are urinary catheterized (14). Patients who are more susceptible to S.
saprophyticus include those who are immunocompromised, HIV positive, diabetic, or elderly
(14).
Staphylococcus and topical burn wounds
The environment of the skin is ideal for bacteria because of the protein rich environment
found in avascular necrotic tissue (16). Also, the avascular nature of the skin inhibits immune
cells from entering via the bloodstream. Additionally, the bacterial release of toxins inhibits the
local immune response. Taken together, the skin provides an enriching area for bacterial growth
(16). While a burn is sterile immediately afterwards, Gram-positive bacteria, including
Staphylococcus, residing in sweat glands and hair follicles survive the burn and quickly multiply
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(16). Gram-positive bacteria colonize the burn area heavily within the first 48 hours without the
application of an antimicrobial agent (16). Biofilms develop within 48-72 hours (16). Within 5 to
7 days the burned area becomes colonized with other Gram-positive and Gram-negative bacteria
and fungi (16). S. aureus is the most common cause of early burn wound infection and has
continued to become challenging to treat due to antibiotic resistance.
Current burn wound treatments
Topical gels decrease morbidity and mortality in patients with burns; however, treatments
have become limited due to antibiotic resistance (16). Silver nitrate is a less commonly used drug
that is effective against Gram-negative bacteria (16). It is scarcely used treatment due to the
potential toxicity, electrolyte imbalances, and discoloration of the wound that may follow
treatment (16). The most common treatment for burns is silver sulfadiazine, a combination of
silver nitrate and sulfadiazine (16). It is a broad spectrum antibiotic that is especially toxic to
Gram-negative bacteria (16). It has been shown to have limited toxicity with once or twice daily
repeated application, with the addition of leukopenia, low white blood cell count. (16). There are
a few reported cases of antimicrobial resistance in silver sulfadiazine and it is less effective in
patients with severe burns because it can only be absorbed within one surface of the epidermal
layer (16). Another burn treatment is Mafenide acetate, a topical broad spectrum cream that is
effective against Gram-negative bacteria but has very little effect on Gram-positive bacteria,
such as the Staphylococcus species (16). This treatment is used sparingly due to its toxicity
profile (16). Acticoat A.B. dressing has been shown to be effective against aerobic Grampositive bacteria, including methicillin resistant Staphylococcus aureus (MRSA), and reduces the
amount of dressing changes needed after injury (16). It is considered the broadest spectrum
bacterial coverage against burn wound pathogens currently (16). Mupirocin, a topical antibiotic,
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has been shown to kill MRSA but should be rotated during treatment to prevent resistance (16).
Nystatin is an antifungal, topical medication that is used in conjunction with antibiotics, due to
its lack of toxicity on bacteria (16). Other non-topical treatments include selective bowel
decontamination, which has been shown to reduce burn wound colonization, and immunization
of tetanus toxin via intramuscular injection (16).
Antimicrobial Gel
Existing antibiotic resistance and the evolving risk for further resistance illuminates the
importance of new treatments to combat newly evolving pathogens of burn wounds. An
antimicrobial gel (AMG) made of seven natural components including antioxidants (vitamin C
and E) and zinc has previously been shown in our lab to inhibit microorganisms that commonly
infect burn wounds. Previous tests have shown that this AMG has the most significant
antimicrobial effects against S. aureus biofilms and planktonic cultures (17). The AMG, from
other lab tests, demonstrate that the effects on pain relief and wound healing are significant (17).
Taken together, the information suggests it would be useful and versatile in the healthcare field.
Therefore, it is important to examine the properties of the AMG on other members of the
Staphylococcus genus (S. capitis, S. epidermidis, S. saprophyticus). It would be useful in wound
care treatments to determine if this predilection for inhibition of S. aureus could be applied to
other Staphylococcal species or if it is specific to only S. aureus.
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MATERIALS AND METHODS
Strains and Growth Conditions
Mannitol salt agar (MSA) stock streak plates for isolated colonies were made for S.
aureus using stock ATCC#25933, S. epidermidis (ATCC #), S. saprophyticus (ATCC #), and S.
capitis was (ATCC # ) . These plates were incubated at 37°C for twenty-four hours, then sealed
with parafilm and placed in a 4°C cooler for storage. This process was repeated every two weeks
to obtain fresh colonies for the following experiments. For all experiments, bacteria were
propagated in Luria-Bertani (LB) broth and MSA plates. When needed, the AMG was
supplemented in LB broth in a weight to volume (w/v) to produce a 10% solution.
Planktonic Broth Challenge Test
Fresh overnight cultures were inoculated for each Staphylococcal species and grown at
37°C for twenty-four hours. An optical density (OD 600) was then obtained. Experimental and
control LB tubes were inoculated using the OD600 reading and adjusting mathematically to
obtain a final concentration of cells of ~1x106 cells/ml. The bacterial mixture was added to either
a 5 ml LB tube (control) or a 5 ml 10% AMG LB broth. The tubes were placed in a 37°C
incubator with shaking (250rpm) for twenty-four hours. Serial dilutions were then performed on
each sample, plated onto MSA or LB agar plates, and incubated at 37°C for twenty-four hours.
The colonies from each plate were then counted. This series was repeated three times to
determine validity.
Biofilms Attachment
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The attachment assay was conducted to observe the effects of AMG on the
Staphylococcus attachment phase for biofilm formation. A 10% solution of AMG LB broth was
added to a 96-well plate with either S. epidermidis, S saprophyticus, S. capitis, and S. aureus
inoculated at an OD600 of 0.01 which is equivalent to 1x106 cells/ml. As a control, S.
epidermidis, S saprophyticus, S. capitis, and S. aureus were also inoculated into LB broth
without AMG and added to separate wells. The plate was then covered in parafilm and placed at
37°C for twenty-four hours. The plate was removed, the remaining liquid was drawn off, washed
with Phosphate Buffered Saline (PBS) and OD600 of the biofilms were measured. A Crystal
Violet assay was then performed by adding 200 ml of 0.001% CV to the wells, incubating for
five minutes, drawing the liquid off and rinsing with PBS, then adding 200 ml 33% Glacial
Acetic Acid for five minutes. This assay was read at OD595 with shaking. This series was
repeated three times to determine validity.
Maturation Assay
A maturation assay was performed by adding S. saprophyticus, S. epidermidis, S. aureus,
and S. capitis LB broth to a 96-well plate to test the effects of AMG on the maturation phase of
biofilm growth. Each species was inoculated in LB and grown for twenty-four hours at 37⁰C
without the addition of AMG. The liquid was then drawn off and 200µl of 10% AMG was added
to half of the wells, while 200µl of LB was added to the other half of each species biofilm for
comparison. The well plate was then incubated at 37°C for twenty four hours. The plate was then
removed and assayed in the same manner as the attachment assay. This series was repeated three
times to determine validity.
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RESULTS
Planktonic cultures of Staphylococcus species with 10% AMG.
It has been previously demonstrated in our lab that among a panel of burn wound
infection microorganisms, that AMG has an increased ability to inhibit S. aureus. We therefore
set out to determine if this inhibition could be seen in other Staphylococcal species using
planktonic cultures. Upon inoculating each strain in LB broth, either with or without 10% AMG,
we found that AMG significantly reduces the growth of S. epidermidis, S. capitis, and S.
saprophyticus as demonstrated by colony forming units (CFU). Figure 1 shows the significant
reduction in CFUs when all three Staphylococcal species are grown with 10% AMG over a
twenty-four-hour period. S epidermidis showed an 81% reduction in CFUs, S. saprophyticus
showed a 100% reduction in CFUs, and S. capitis showed a 94% reduction in CFUs when
compared to their LB broth only (no AMG) matched controls. This data is comparatively similar
to the prior data we obtained when S. aureus is inoculated into LB AMG with a robust inhibition
of CFUs over a 24-hour period. Taken together, it would appear that the AMG inhibits all
members of the Staphylococcal family, at least in planktonic culture, equally and not specific for
only S. aureus inhibition. Figure 2 and 3 are representative photos of one trial of S.
saprophyticus planktonic cultures with AMG (Figure 3) or without AMG (Figure 2). As shown
in all three trials, addition of AMG to the culture produced no viable colonies of S.
saprophyticus. Trials with S. capitis and S. epidermidis produced a similar trend with minimal
bacterial growth on all dilution plates of the cultures containing 10% AMG (photos not shown).

12

Effect of 10% AMG on Staphyococcus Growth (CFU)
100% reduction

9

94.4% reduction
8

81.7% reduction

7

CFU (log10)

6
5
4
3
2

p- value:
0.0256

p-value: less
than 0.0001

1

p-value:
0.0060

0
S epidermidis

S saprophyticus
Control

S capitis

10% AMG

Figure 1: Graphical representation of 24 hour planktonic cultures of Staphylococcal species with
or without AMG (three separate trials).
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Figure 2: S. saprophyticus (without AMG) serially diluted to plate 6 which produced 148
bacterial colonies (one out of three trials)

Figure 3: S. saprophyticus (with 10% AMG) serially diluted to plate 1 which produced no
bacterial colonies (one out of three trials)

Biofilm, attachment phase, of Staphylococcus species with 10% AMG.
After demonstrating that AMG inhibits not only S. aureus, but also planktonic cultures of S.
capitis, S. epidermidis, and S. saprophyticus, we turned our attention to biofilm formation.
Biofilms form in discreet ordered steps beginning with the attachment of planktonic cells to a
surface. It was postulated that AMG could inhibit the early stage of bacterial biofilm formation.
AMG showed a significant reduction in biofilm attachment among all Staphylococcal species
tested. Two different methods were used to quantify biofilm attachment. The first method used
optical density as a measure to determine the amount of bacterial density present (Figure 4). S.
capitis density decreased by 63%, S. epidermidis density decreased by 47%, and S.
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saprophyticus density decreased by 57% with the application of AMG as compared to controls
with only LB broth and bacteria. While all three bacterial species were reduced in their ability to
attach to the 96-well plates, they did so in different amounts of reduction as compared to the
planktonic growth. In planktonic growth, S. saprophyticus was completely inhibited followed by
S. capitis, and then S. epidermidis. In the attachment phase, S. saprophyticus had the most
growth, followed by S. epidermidis and S. capitis. These differences could be due to the growth
characteristics of planktonic verses biofilm growth. In planktonic growth, the cells are
continuously bathed in the AMG, whereas in biofilm growth, the bacteria grow in communities
and the layers of bacteria can protect the community and keep the AMG from penetrating the
biofilm.

Staphylococcal Biofilm Attachment (Density)
0.4

57.1% reduction
0.35
0.3

OD 600

0.25

47.2% reduction
63.2% reduction

0.2
0.15
0.1

p-value:
0.0340

p-value:
0.1523

p-value:
0.0765

0.05
0

S capitis

S epidermidis
Control

S saprophyticus

10% AMG

Figure 4: Graphical representation of biofilm growth over a 24 hour period of Staphylococcal
species with AMG added at the same time as bacteria – Attachment Phase OD600 test (three
separate trials).
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The second method used CV staining and OD595 readings to determine the amount of
biofilm density present (Figure 5). S. capitis density decreased by 19%, S. epidermidis density
decreased by 39%, and S. saprophyticus density decreased by 55% with the application of AMG
as compared to controls with only LB broth and bacteria. This data correlated with the optical
density data from Figure 4 with all three species being reduced in their biofilm attachment
abilities when AMG is added. Again, this inhibition is not as pronounced as the planktonic
inhibition due to the different growth characteristics between the two forms. This inhibition does
support the findings of the optical density data as they are proportional to the decreases seen
from the OD600 readings.

Staphylococcal Biofilm Attachment (CV density)
0.3

55.5% reduction

0.25

OD 595

0.2

0.15

0.1

39.1% reduction
p-value:
0.1248

19.5% reduction
p- value:
0.0968

P- value:
0.0326

0.05

0
S capitis

S epidermidis
Control

S saprophyticus

10% AMG

Figure 5: Graphical representation of 24-hour biofilm growth of Staphylococcal species with
AMG added at the same time as bacteria – Attachment Phase – CV test (three separate trials).
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Biofilm, maturation phase, of Staphylococcus species with 10% AMG.
After demonstrating that AMG inhibits the attachment phase of biofilms formed by S.
capitis, S. epidermidis, and S. saprophyticus, the second phase of biofilm growth, mature
biofilms, was evaluated. In many health care infections, biofilms are already formed on
implanted devices or wounds. Treatments must then be directed at destroying these pre-formed
biofilms that can typically be 10 to 1000X more resistant to antibiotics. We therefore wanted to
determine if AMG could inhibit a later stage of bacterial biofilm formation i.e. an established
biofilm on a surface. For this biofilm evaluation, bacteria were allowed to grow without AMG
for 24 hours to create an established bacterial biofilm on the plate surface. After 24 hours, the
media was removed, 10% AMG-LB was added and the biofilms were incubated for another 24
hours. The two methods for biofilm quantification were used as previously described. OD600
readings indicated that S. capitis density decreased by 39.9%, S. epidermidis density decreased
by 47.9%, and S. saprophyticus density decreased by 38.1% with the application of AMG as
compared to controls with only LB broth and bacteria (Figure 6). All three bacterial species
demonstrated reductions in the mature biofilm coverage in the 96-well plates Again, varying
amounts of reduction for each species was found when compared to the planktonic growth and
the biofilm attachment assay. In planktonic growth, S. saprophyticus was completely inhibited
followed by S. capitis, and then S. epidermidis and in the biofilm attachment phase, S.
saprophyticus had the most inhibition, followed by S. capitis, and S. epidermidis. In the mature
biofilm eradication, S. epidermidis had the largest reduction compared to controls, followed by S.
capitis, and then S. saprophyticus. Since the mature biofilm has different characteristics than
planktonic and even the biofilm attachment phases, it could be that S. epidermidis is more
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sensitive at this time point verses the attachment phase to the inhibitory effects of AMG than the
other Staphylococcal species.

Staphylococcal Biofilm Maturation (Density)
0.9
0.8

38.1% reduction

0.7

OD 600

0.6

P-value:
0.0375

39.9% reduction

0.5

p-value:
0.1147

0.4

47.9% reduction

P-value:
0.0643

0.3
0.2
0.1
0

S saprophyticus

S capitis
Control

S epidermidis

10% AMG

Figure 6: Graphical representation of 24-hour biofilm growth of Staphylococcal species with
AMG only added after bacteria have an initial 24 hour growth – Maturation Phase – OD600 test
(three separate trials).

The second assessment method again used CV staining and OD595 readings to determine the
amount of biofilm density present (Figure 7). At this point we found unexpected results. In the
trials using staining for mature biofilm eradication, there was a large increase in experimental
verses the control wells for all three Staphylococcal species. These results may be due to errors
made during the staining and washing process as this data is in complete odds against all of the
other data collected in these experiments, including the OD600 readings of the mature biofilm
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data. We are currently exploring and re-examining the staining process and will run additional
experiments to determine the cause of these unexpected results.

Staphylococcal Biofilm Density (CV Stain)
0.3

0.25

OD 595

0.2

0.15

0.1

0.05

0
S saprophyticus

S capitis
Control

S epidermidis

10% AMG

Figure 7: Graphical representation of 24-hour biofilm growth of Staphylococcal species with
AMG only added after bacteria have an initial 24 hour growth – Maturation Phase – CV test
(three separate trials).

DISCUSSION AND CONCLUSION
Antibiotic resistance is an ever-expanding problem in healthcare and new novel
medications are needed in treatment rotation to prevent further resistance. The Staphylococcus
genus is the most common cause of early burn would infections and nontoxic treatments are
needed to further promote healing of burns without complications. At this time, the majority of
treatment for burn wound infections have deficiencies such as toxicity, resistance, targeted
specificity, and stability that do not promote positive outcomes for the patient. The AMG
presented in this thesis has already shown to be a promising and powerful option for the
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treatment of S. aureus infections. The results of this thesis, show that AMG reduced colony
forming units and biofilm attachment, suggesting that this could be used as initial treatment after
a burn wound has occurred. This data shows that the inhibitory effects of AMG are universally
present in all species of Staphylococcus testing. If applied directly after a burn, it could prevent
the attachment of Staphylococcus bacteria and inhibit the establishment of biofilms, resulting in
the prevention of biofilm maturation that are typically highly drug resistant. AMG was less
effective in maturation, suggesting that the biofilm matrix is more complex once completely
developed and may prevent the AMG from reaching all cells. AMG significantly reduced the
colony forming units, completely depleting S saprophyticus colonies. This suggests that it has a
greater effect on individual planktonic bacteria than biofilms.
These results support that AMG reduced Staphylococcus biofilm attachment, maturation,
and planktonic forms of growth. Future plans include evaluating Gram-positive bacteria and
other cocci bacteria to evaluate the broad spectrum coverage of AMG. Additionally, varying
concentrations of AMG will be used to determine if an increase in AMG would be better at
inhibiting the hardy mature biofilms. Lastly, we plan to delineate the mechanism of action AMG
has on bacteria, specifically Staphylococcus. AMG should be studied further to examine its
benefits in application to not only burn treatments, but also as a means to be used
prophylactically on medical devices and in conjunction with other treatments to prevent
antibiotic resistance.
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